Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Gondkar, Kirtia; b | Patel, Krishnaa; b | Krishnappa, Shobhac | Patil, Akkamahadevid | Nair, Bipinb | Sundaram, Gopinath Meenakshie | Zea, Tan Tuanf | Kumar, Prashanta; g; *
Affiliations: [a] Institute of Bioinformatics, International Technology Park, Bangalore, India | [b] Amrita School of Biotechnology, Amrita Vishwa Vidyapeetham, Kollam, India | [c] Department of Surgical Oncology, Kidwai Memorial Institute of Oncology, Bangalore, India | [d] Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India | [e] Department of Biochemistry, Central Food Technological Research Institute, Mysore, India | [f] Cancer Science Institute of Singapore, National University of Singapore, Singapore | [g] Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India
Correspondence: [*] Corresponding author: Prashant Kumar, Faculty Scientist, %****␣cbm-25-cbm190013_temp.tex␣Line␣25␣**** Institute of Bioinformatics, 7 th floor, Discoverer building, International Technology Park, Bangalore 560 066, India. E-mail: prashant@ibioinformatics.org.
Abstract: BACKGROUND: Transcription factors are commonly deregulated in various cancers. Here, we evaluated role of ELF3 in pathogenesis of bladder carcinoma (BCa). MATERIALS AND METHODS: We confirmed ELF3 expression pattern in BCa cell lines using western blot; and in different grades of tumors using Immunohistochemistry. Cell invasion assay was employed to demonstrate potential role of ELF3 in EMT. RESULTS AND CONCLUSION: ELF3 showed selective expression in low-grade cell lines and tumor tissues. Overexpression of ELF3 in mesenchymal cell line UMUC3 resulted in reduced invasion and decreased expression of mesenchymal markers. We observed association of low ELF3 expression with increased risk and overall poor survival using publicly available data. ELF3-modulated reversal of EMT might be a useful strategy in the treatment of bladder cancer.
Keywords: EMT, bladder cancer, ETS transcription factor
DOI: 10.3233/CBM-190013
Journal: Cancer Biomarkers, vol. 25, no. 2, pp. 223-232, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl